Emerging Companies Advisory Board
This CEO advisory board serves the needs of small to medium size member companies, most of which do not yet have major products approved or on the market. It addresses issues affecting smaller companies and facilitates the development of BIOTECanada’s programs and policy positions to enhance the development of these companies.
Health Advisory Board
Comprised of representatives from Canada’s leading-edge developers of biological therapeutics and vaccines, the board engages leading decision makers on critical issues to ensure innovative life-saving biotech treatments are developed in Canada and are available to Canadian citizens. The advisory board acts through a series of sub-committees to address regulatory, product access, intellectual property and industrial development issues that affect the entire biotech health-sector from start-up to multi-national.
Agriculture and Nutrition Advisory Board
This board seeks to ensure Canada is globally competitive in agricultural biotechnology. Its members work with key government officials and stakeholders to create a public policy and regulatory environment that promotes the development of agricultural biotechnology in Canada. Members of the advisory board represent leading providers of innovative science-based technology for agriculture.
Industrial & Environmental Committee
This committee works on the policy framework for industrial and environmental biotechnology. It seeks to address the issues in this growing sector including standards, awareness and market adoption/opportunities.
Vaccine Industry Committee (VIC)
The VIC is comprised of Canada’s major vaccine developers and suppliers. Members actively engage with the federal, provincial and territorial governments to foster full access and availability of all vaccines including existing, new and innovative vaccines for all Canadians. The committee also promotes the high quality nature of Canadian research, development, manufacturing, and distribution of vaccines, and develops awareness of the value of vaccines to the Canadian health care system.